Search Results - "Nair, Satheesh P."

Refine Results
  1. 1

    Unexpected hepatitis B virus transmission after liver transplant from nucleic acid testing‐ and serology‐negative liver donors who are hepatitis C viremic by Kreitman, Kyle R., Kothadia, Jiten P., Nair, Satheesh P., Maliakkal, Benedict J.

    Published in Hepatology research (01-12-2021)
    “…The opioid epidemic has led to increased availability of organs for liver transplantation. The success of direct‐acting antiviral therapy for hepatitis C (HCV)…”
    Get full text
    Journal Article
  2. 2

    Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature by Kreitman, Kyle, Kothadia, Jiten P., Nair, Satheesh

    Published in Case reports in hepatology (10-03-2020)
    “…Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. We…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature by Abutineh, Iman, Kreitman, Kyle, Kothadia, Jiten P., Ali, Bilal, Jain, Richa, Clark, Ian, Maliakkal, Benedict J., Nair, Satheesh P.

    Published in Case reports in hepatology (03-06-2021)
    “…Infection with hepatitis A virus is usually a self-limited illness that rarely results in fulminant liver failure. Severe hemolysis is an uncommon complication…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid by Satapathy, Sanjaya K., Jones, Ollie D., Vanatta, Jason M., Kamal, Faisal, Kedia, Satish K., Jiang, Yu, Nair, Satheesh P., Eason, James D.

    Published in Transplantation direct (01-07-2017)
    “…Liver transplant (LT) recipients with autoimmune liver disease (primary sclerosing cholangitis, primary biliary cholangitis, autoimmune hepatitis) are at…”
    Get full text
    Journal Article
  7. 7

    Role of MRCP in Diagnosing Biliary Anastomotic Strictures After Liver Transplantation: A Single Tertiary Care Center Experience by Akbar, Ali, Tran, Quynh T., Nair, Satheesh P., Parikh, Salil, Bilal, Muhammad, Ismail, Mohammed, Vanatta, Jason M., Eason, James D., Satapathy, Sanjaya K.

    Published in Transplantation direct (01-05-2018)
    “…Biliary strictures (BS) are common complication after liver transplantation. We aimed to determine the accuracy of magnetic resonance cholagiopancreatography…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors by Satapathy, Sanjaya K, Vanatta, Jason M, Helmick, Ryan A, Flowers, Albert, Kedia, Satish K, Jiang, Yu, Ali, Bilal, Eason, James, Nair, Satheesh P, Ibebuogu, Uzoma N

    Published in Transplantation (01-04-2017)
    “…BACKGROUNDCoronary artery disease (CAD) is a significant problem during evaluation for liver transplantation (LT). We aim to assess survival in LT recipients…”
    Get full text
    Journal Article
  12. 12

    Predicting harmful alcohol relapse after liver transplant: The HALT score by Satapathy, Sanjaya K., Thornburgh, Cody, Heda, Rajiv, Jiang, Yu, Kedia, Satish K., Nair, Satheesh P., Eason, James D., Maluf, Daniel

    Published in Clinical transplantation (01-09-2020)
    “…Background Alcohol‐associated liver disease (AALD) is a rapidly growing indication for liver transplantation (LT). We aimed to examine various clinical,…”
    Get full text
    Journal Article
  13. 13

    No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant by Satapathy, Sanjaya K., Das, Kanak, Kocak, Mehmet, Helmick, Ryan A., Eason, James D., Nair, Satheesh P., Vanatta, Jason M.

    Published in Clinical transplantation (01-05-2018)
    “…Background Sorafenib has shown survival benefits in patients with advanced HCC; however, limited data are available on its role in OLT recipients with advanced…”
    Get full text
    Journal Article
  14. 14

    Achieving Sustained Virological Response in Liver Transplant Recipients With Hepatitis C Decreases Risk of Decline in Renal Function by Satapathy, Sanjaya K., Joglekar, Kiran, Molnar, Miklos Z., Ali, Bilal, Gonzalez, Humberto C., Vanatta, Jason M., Eason, James D., Nair, Satheesh P.

    Published in Liver transplantation (01-08-2018)
    “…The effect of antiviral therapy (AVT) on kidney function in liver transplantation (LT) recipients has not been well described despite known association of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effect of opioid treatment on clinical outcomes among cirrhotic patients in the United States by Ali, Bilal, Jiang, Yu, Agbim, Uchenna, Kedia, Satish K., Satapathy, Sanjaya K., Barnes, Matthew, Maliakkal, Benedict, Nair, Satheesh P., Eason, James D., Gonzalez, Humberto C.

    Published in Clinical transplantation (01-06-2020)
    “…Background Opioid medications are frequently used to address pain among patients with cirrhosis, including those on the liver transplant (LT) waitlist and…”
    Get full text
    Journal Article
  17. 17

    Enterococcus casseliflavus, Streptococcus equinus and Klebsiella oxytoca septicaemia associated with perinephric haematoma in a post-liver transplant patient with allograft cirrhosis by Heda, Rajiv Prakash, Savage, Yolanda, Nair, Satheesh P, Verma, Rajanshu

    Published in BMJ case reports (01-08-2019)
    “…Liver transplant recipients are immunocompromised by the virtue of being on immunosuppressive agents which put them at risk of having infections from unusual…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Prevalence of Obesity and Diabetes in Patients With Cryptogenic Cirrhosis: A Case-Control Study by Poonawala, Asma, Nair, Satheesh P, Thuluvath, Paul J

    Published in Hepatology (Baltimore, Md.) (01-10-2000)
    “…It has recently been suggested that nonalcoholic steatohepatitis (NASH) is an under-recognized cause of cryptogenic cirrhosis (CC) on the basis of higher…”
    Get full text
    Journal Article
  20. 20